Mission Wealth Management’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.5K | Hold |
10,651
| – | – | ﹤0.01% | 644 |
|
|
2025
Q1 | $23.8K | Hold |
10,651
| – | – | ﹤0.01% | 625 |
|
|
2024
Q4 | $31.2K | Hold |
10,651
| – | – | ﹤0.01% | 617 |
|
|
2024
Q3 | $27.7K | Hold |
10,651
| – | – | ﹤0.01% | 631 |
|
|
2024
Q2 | $31.5K | Hold |
10,651
| – | – | ﹤0.01% | 610 |
|
|
2024
Q1 | $48.3K | Hold |
10,651
| – | – | ﹤0.01% | 625 |
|
|
2023
Q4 | $60.8K | Hold |
10,651
| – | – | ﹤0.01% | 549 |
|
|
2023
Q3 | $49K | Hold |
10,651
| – | – | ﹤0.01% | 517 |
|
|
2023
Q2 | $68.8K | Hold |
10,651
| – | – | ﹤0.01% | 516 |
|
|
2023
Q1 | $80.3K | Hold |
10,651
| – | – | ﹤0.01% | 502 |
|
|
2022
Q4 | $108K | Hold |
10,651
| – | – | 0.01% | 484 |
|
|
2022
Q3 | $105K | Hold |
10,651
| – | – | 0.01% | 463 |
|
|
2022
Q2 | $113K | Hold |
10,651
| – | – | 0.01% | 474 |
|
|
2022
Q1 | $104K | Hold |
10,651
| – | – | ﹤0.01% | 491 |
|
|
2021
Q4 | $152K | Sell |
10,651
-20,000
| -65% | -$285K | 0.01% | 497 |
|
|
2021
Q3 | $614K | Hold |
30,651
| – | – | 0.03% | 237 |
|
|
2021
Q2 | $674K | Buy |
+30,651
| New | +$674K | 0.04% | 229 |
|